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Introduction
Type 1 diabetes (T1D) is an autoimmune disease whose etiology is not fully understood. It is a chronic disease 
in which insulin-producing pancreatic β cells undergo autoimmune attack. The increased incidence of  T1D 
indicates that environmental factors are important mediators in the pathogenesis. Among these exogenous 
factors, a number of  epidemiological and experimental results suggest that viral infection by enteroviruses 
such as coxsackieviruses or echoviruses may contribute to the development of  T1D (1–4). Indeed, enteroviral 
proteins have been observed in pancreatic islets from T1D patients (5–7). Moreover, experimental models 
showed that infection with a coxsackievirus (CVB4E2) isolated from a patient with diabetic ketoacidosis (8) 
induces diabetes in mice (9). Additionally, coxsackievirus infection gives rise to diabetes in hyperglycemic 
mice engrafted with human islets (10). Lastly, genetic and experimental studies showed that rare variants of  
genes involved in recognition of  dsRNA, a byproduct of  replication of  most viruses, protect against T1D (1, 
4). However, a final link between viral infection and the onset of  T1D is still lacking. Furthermore, mecha-
nisms involved in the alteration of  human β cell function following viral infection are unknown. For example, 
recent data indicate that hyperglycemic mice rescued by engrafted human islets became diabetic upon infec-
tion with coxsackieviruses. Importantly, diabetes was not due to human β cell death, but instead, to decreased 
insulin production, suggesting β cell loss of  identity (10).
Rodent models have been useful to increase our understanding of  how viral infections could contrib-
ute to the development of  T1D in humans (1–4). For instance, CVB5 Faulkner and MCA strains, which 
had been adapted to enter rodent insulinoma cells such as MIN6 cells (11), were shown to disrupt insulin 
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granule stores in this cell line (12). However, several differences exist between humans and rodents with 
respect to enteroviral infection. For example, coxsackievirus and adenovirus receptor (CAR) is expressed in 
human β cells, while it is not or barely detectable in murine β cells (10, 13). Moreover, the β cell’s sensitiv-
ity to different coxsackievirus strains varies between species (14). Thus, studying how enteroviral infection 
could lead to T1D in humans is of  major importance. Therefore, the use of  the functional human β cell line 
EndoC-βH1 (15) represents a suitable tool to better understand how viral infection could contribute to the 
development of  T1D in humans.
Enteroviral, and indeed most viral, replication results in the formation of  dsRNAs (16). In the present 
study, we treated EndoC-βH1 cells with polyinosinic-polycytidylic acid (PolyI:C). PolyI:C is a synthetic 
dsRNA recognized in the cytoplasm by dsRNA pattern recognition receptors (PRRs) that mimics, at least 
in part, the effects of  viral infection on β cells (16, 17). We demonstrated that human β cells dedifferentiate 
following PolyI:C treatment and enteroviral infection. The expression of  β cell–specific genes decreased, 
while progenitor-like genes such as SOX9 were activated. SOX9 was induced in an NF-κB–dependent man-
ner, at least in part in a paracrine non–cell-autonomous fashion through the secretion of  cytokines such 
as IFN-α. Finally, we discovered SOX9 targets in human β cells that represent potentially new marks of  
human β cell dedifferentiation in T1D.
Results
Human β cells dedifferentiate upon PolyI:C treatment. We first asked whether PolyI:C could disturb β cell identity. 
To this end, we transfected EndoC-βH1 cells with PolyI:C and performed global transcriptomic analyses 24 
hours later. Mock-transfected cells (incubated with Lipofectamine alone) were used as control. As expected 
(18), PolyI:C treatment induced the expression of  PRRs such as TLR3, IFIH1, and DDX58 that recognize 
dsRNA, demonstrating the sensitivity of  EndoC-βH1 cells to PolyI:C (Supplemental Figure 1, A and B; sup-
plemental material available online with this article; https://doi.org/10.1172/jci.insight.97732DS1). PolyI:C 
treatment also induces the expression of  B2M (β-2 microglobulin) (Supplemental Figure 1C). Interestingly, 
PolyI:C treatment decreased the expression of  many genes related to β cell identity or function (Figure 1A). 
For example, the expression of  the transcription factor MAFA decreased following PolyI:C treatment (Figure 
1B), which was further confirmed at the protein level (Figure 1, C and D for quantification). INS mRNA 
levels also decreased, as was the case for its pre-mRNA, suggesting a decrease in INS transcription by PolyI:C 
treatment (Figure 1B). We also observed a decrease in the expression of  genes linked to β cell function, such 
as G6PC2 and SLC30A8 (ZNT8) (Figure 1B). Finally, PolyI:C treatment decreased glucose-stimulated insulin 
secretion (Figure 1E).
We next asked whether PolyI:C treatment activates the expression of  genes normally not or barely 
expressed in pancreatic β cells. Global transcriptomic analysis indicated that expression of  NEUROG3, an 
endocrine progenitor marker, GCG, an α cell marker, HNF1B and CFTR, 2 ductal markers, and PTF1A and 
AMY2A, 2 acinar markers, were not induced by PolyI:C (Figure 2A). VCAN (versican) that encodes a large 
extracellular matrix proteoglycan and the tyrosine-protein kinase LYN were highly induced (Figure 2A). 
It is also the case for the 2 β cell disallowed genes LRIG3 (leucine-rich repeats and immunoglobulin-like 
domains 3) and LMO4 (LIM domain only 4) (Supplemental Figure 2) (19, 20). Interestingly, the expres-
sion level of  mRNA encoding the 3 transcription factors SOX9, HES1, and MYC, normally barely or not 
expressed in human β cells (primary and EndoC-βH1 cells), was increased upon treatment with PolyI:C 
(Figure 2A). Quantitative reverse transcription PCR (RT-qPCR) analyses further confirmed the induction of  
SOX9, HES1, and MYC mRNA upon PolyI:C treatment (Figure 2B). SOX9 induction was further validated 
at the protein level by Western blot (Figure 2C). Finally, transfection of  PolyI:C into human islets induced 
SOX9 expression in insulin-positive β cells (Figure 2D).
PolyI:C treatment induced a nearly 3-fold increase in the number of  apoptotic cells (from 6.6% ± 2.8% 
to 15% ± 2%), indicating that PolyI:C treatment induces some β cell death in addition to dedifferentiation 
(Supplemental Figure 3, A and B). To exclude the possibility that dedifferentiation occurred in dying cells, 
we sorted annexin V/propidium iodide double-negative cells and performed RT-qPCR analyses. Remark-
ably, we observed similar genes down- and upregulated in live cells when compared with the bulk experi-
ment (compare Supplemental Figure 3, C and D with Figures 1B and 2B).
By mining our transcriptomic data, we observed that PolyI:C treatment induced the expression of  sev-
eral genes linked to antiviral responses, coding for chemokines or for proteins related to immune response 
(Supplemental Figure 4) that were previously shown to be induced upon infection of  human pancreatic 
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Figure 1. Downregulation of human β cell identity in PolyI:C-transfected EndoC-βH1 cells. EndoC-βH1 cells were either mock transfected (control) 
or transfected with PolyI:C and analyzed 24 hours later. (A and B) Heatmap from global transcriptomic analysis and RT-qPCR data represent down-
regulated β cell genes (n = 3). (C and D) Western blot analysis (representative of 3 independent experiments) and quantification of MAFA expres-
sion (n = 3). (E) EndoC-βH1 cells were either mock transfected (control, white) or transfected with PolyI:C (gray) and glucose-stimulated insulin 
secretion (GSIS) was performed 6 days later with 0 or 20 mM glucose. Insulin secreted in ng/106 cells is represented (n = 3). Data from RT-qPCR, 
Western blot, and GSIS analyses represent the mean ± SD of 3 independent experiments. *P < 0.05, **P < 0.01, and ***P < 0.001 relative to BSA by 
1-way ANOVA with Bonferroni’s correction.
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Figure 2. PolyI:C induces the expression of SOX9, HES1, and MYC in human β cells. (A–C) EndoC-βH1 cells were either mock transfected (CTRL) or 
transfected with PolyI:C and analyzed 24 hours later (n = 3). (A and B) Heatmap from global transcriptomic analysis and RT-qPCR data represent 
induced genes. (C) Western blot analysis of SOX9 expression (n = 3; n1, n2, and n3 correspond to 3 independent experiments). (D) Primary human islet 
cells were dissociated and either mock transfected (CTRL) or transfected with PolyI:C and analyzed 24 hours later by immunocytochemistry. Nuclei are 
stained with Hoechst 33342 stain (blue), insulin is in red, and SOX9 is in green. Arrowheads point to insulin+ (INS+) cells that stain positive for SOX9 
following PolyI:C treatment. Scale bars: 25 μm. The inset shows a higher-magnification image (×2.1 magnification; scale bar: 5 μm). Representative 
images of 4 independent experiments. (E–G) EndoC-βH1 cells were infected with enteroviruses at 5 × 104 TCID50 and harvested 24 hours later. (E) West-
ern blot analysis of VP1 expression (n = 3). (F and G) qPCR analyses of SOX9, MYC, and HES1 expression (n = 3). (H) Human islets were infected with 
enteroviruses at 5 × 107 TCID50 and harvested 24 hours later. Western blot analyses of VP1 and SOX9 expression are shown (representative images of 3 
independent experiments). Data from RT-qPCR, Western blots, and immunofluorescence represent the mean ± SD of 3 independent experiments. *P < 
0.05, **P < 0.01, and ***P < 0.001 relative to control by Student’s t test. CVB5-F, coxsackievirus strain B5 Faulkner; EV-9 B, echovirus 9 Barty.
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islets by coxsackieviruses (10, 21). We thus tested whether infection with enteroviruses such as CVB5 and 
echovirus 9 (EV-9) upregulated the expression of  pancreatic progenitor markers in EndoC-βH1 cells. CVB5 
Faulkner, EV-9 Barty, and EV-9 DM strains efficiently infected EndoC-βH1 cells, as demonstrated by the 
detection of  the major viral capsid protein VP1 (Figure 2E). Importantly, infection of  EndoC-βH1 cells 
by all 3 virus strains induced SOX9, HES1, and MYC expression (Figure 2, F and G), as demonstrated for 
PolyI:C. Infection by all 3 virus strains also increased SOX9 levels in human pancreatic islets (Figure 2H).
Taken together, these data indicate that dedifferentiation occurs in dsRNA-treated human β cells, as is 
the case following infection with enteroviruses.
The NF-κB subunit RELA mediates the induction of  SOX9 by PolyI:C in EndoC-βH1 cells. To determine the 
mechanisms involved in β cell dedifferentiation induced by PolyI:C, we searched for pathways regulated 
by PolyI:C using gene set enrichment analysis (GSEA). The NF-κB pathway was listed among the top 
regulated pathways (Figure 3A). PolyI:C treatment induced the nuclear translocation of  RELA, a major 
subunit of  NF-κB (Figure 3B) and upregulated the expression of  NF-κB downstream targets such as TNFA, 
IL8, and IL6 (Figure 3C). Moreover, efficient siRNA-mediated downregulation of  RELA (Figure 3, D and 
E) reduced TNFA, IL8 (Figure 3D), and IL6 (data not shown) induction by PolyI:C. Remarkably, RELA 
knockdown weakened the induction of  SOX9 by PolyI:C, as measured at the mRNA (Figure 3D) and 
protein levels (Figure 3, E and F). To strengthen our hypothesis that RELA is largely responsible for the 
induction of  SOX9 upon PolyI:C treatment, we tested the effect of  additional NF-κB activators. Incuba-
tion of  EndoC-βH1 cells with a cocktail of  proinflammatory cytokines (TNF-α + IL-1β + IFN-γ), which 
are involved in β cell dysfunction and death through NF-κB in T1D-related models (22), induced SOX9 
expression both at the mRNA and protein levels (Figure 4, A and B). Treatment of  human islets with 
cytokines also induced SOX9 expression in β cells (Figure 4C). PMA, another potent NF-κB activator 
that induces TNFA and IL8 expression in EndoC-βH1 cells (Figure 4D), increased SOX9, HES1, and MYC 
expression while decreasing MAFA and SLC30A8 levels (Figure 4, D and E and Supplemental Figure 5A). 
SOX9 induction by PMA treatment was prevented when the NF-κB subunit RELA was downregulated 
with siRNA (Figure 4, D–F) or inhibited using ammonium pyrrolidinedithiocarbamate (PDTC), a potent 
NF-κB inhibitor (Supplemental Figure 5, A and B).
These data indicate that PolyI:C activates the NF-κB pathway through RELA, which in turn is neces-
sary for SOX9 induction in human β cells.
PolyI:C-treated EndoC-βH1 cells secrete factors that disrupt β cell identity of  neighboring cells. In models of  
T1D, CD8+ T cells, endothelial cells, and macrophages secrete proinflammatory cytokines that presum-
ably induce β cell dysfunction and death (22). β Cells themselves also secrete proinflammatory cyto-
kines following viral infection or cytokine exposure (refs. 21, 22 and Supplemental Figure 4). We won-
dered whether factors secreted by β cells following PolyI:C transfection could disrupt neighboring β 
cell identity in a paracrine non–cell-autonomous fashion. To test this hypothesis, we incubated fresh 
(non–PolyI:C-transfected) EndoC-βH1 cells with the conditioned medium of  PolyI:C-treated EndoC-
βH1 cells. Interestingly, SOX9 (both mRNA and protein levels) increased following incubation with con-
ditioned medium from PolyI:C-treated cells (Figure 5, A and B). This induction was not due to PolyI:C 
that remained present in the conditioned medium, as (a) addition of  PolyI:C to the culture medium 
(without transfection) did not modulate gene expression in naive EndoC-βH1 cells even at high concen-
tration (Supplemental Figure 6A), and (b) treatment of  conditioned medium from PolyI:C-transfected 
cells with RNAse-A did not modify its ability to induce SOX9 expression in naive cells (Supplemental 
Figure 6B). Taken together, these observations indicate that SOX9 induction by conditioned medium 
was exclusively due to secreted factors.
We next searched for the secreted factor(s) that induce SOX9 expression in a paracrine non–cell-
autonomous fashion. Further mining our microarray data indicated that PolyI:C treatment upregulated 
the expression of  many secreted cytokines. This is, for example, the case for IFN, IL, and TNF family 
members (Figure 3C and Figure 5, C and D). On the other hand, the expression of  IL1B and IFNG was 
not induced by PolyI:C (Figure 5C). We thus tested whether selected cytokines induced by PolyI:C activate 
SOX9 expression. It was not the case for TNF-α (Figure 5, E and F). In contrast, IFN-α induced SOX9 
expression both at the mRNA and protein levels. Moreover, coincubation of  IFN-α with TNF-α further 
increased SOX9 expression (Figure 5E). Note that conditioned medium from PolyI:C-treated cells induced 
a 46.3 ± 18-fold increase in SOX9 mRNA, while IFN-α plus TNF-α increased SOX9 mRNA by only 20.3 ± 
2.3-fold. Thus, there must be additional factors that contribute to the change in SOX9 mRNA.
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These data indicate that PolyI:C treatment induces the production of  secreted factors such as IFN-α 
and TNF-α that could induce SOX9 expression in a non–cell-autonomous fashion.
SOX9 targets in dedifferentiated human β cells. At this point, our data indicated that inflammatory 
signals induced human β cell dedifferentiation and SOX9 could represent an important transcription 
factor in this process. To further define the role of  SOX9 in β cells, we searched for its target genes. 
Previous data described HNF1B, ONECUT1, and FOXA2 as SOX9 targets in mouse pancreatic duct cells 
(23). None of  them was induced by PolyI:C in EndoC-βH1 cells (Figure 6A). To define novel SOX9 
targets, we overexpressed SOX9 in EndoC-βH1 cells. We transfected EndoC-βH1 cells with either an 
MCS-ires-GFP (control) or a SOX9-ires-GFP plasmid and sorted GFP+ cells by FACS (Figure 6B). SOX9 
overexpression induced a downregulation of  INS presplicing mRNA and several β cell–related tran-
scription factors such as MAFA, PDX1, and NKX6-1 (Figure 6C). This expression pattern resembles the 
one observed in transgenic mice with ectopic expression of  SOX9 in β cells (24). We also overexpressed 
in EndoC-βH1 cells a constitutively trans-activating SOX9 mutant (VP16-SOX9ΔTAD) in which the 
SOX9 transactivation domain (TAD) was replaced by VP16 that increases SOX9 transcriptional activ-
ity (Supplemental Figure 7) (25). We performed global transcriptomic analyses and detected 115 genes 
upregulated by both wild-type SOX9 (SOX9WT) and VP16-SOX9ΔTAD constructs (Figure 6, D and 
E). We next crossed the list of  genes induced by WT and mutant super transactivator form SOX9 with 
one of  the genes induced following PolyI:C treatment. We obtained a list of  25 genes induced by both 
SOX9 and PolyI:C (Figure 7A) and selected 4 of  them (CTGF, LRRTM2, DEPTOR, and MAML2). 
We confirmed by RT-qPCR their upregulation following SOX9WT and VP16-SOX9ΔTAD transfection 
(Figure 7B) and following PolyI:C treatment (see below). Moreover, when SOX9 expression was blunt-
ed using siRNA (Figure 7, C and D), CTGF, LRRTM2, DEPTOR, and MAML2 induction by PolyI:C 
was decreased (Figure 7E). Sox9 induction has recently been observed in dedifferentiated β cells from 
nonobese diabetic (NOD) mice (26). Interestingly, we found that 10 out of  25 genes induced by SOX9 
overexpression and PolyI:C treatment have been described as induced in dedifferentiated β cells from 
NOD mice and Ctgf, Lrrtm2, Deptor, and Maml2 belonged to this list (Supplemental Figure 8).
Taken together, our data show that SOX9 and its targets represent potentially new markers of  human 
β cell dedifferentiation.
Discussion
The concept of  loss of  β cell identity or dedifferentiation as a cause of  diabetes mellitus is gaining promi-
nence. Dedifferentiation has been observed in several models where β cells were challenged with environ-
mental cues such as glucotoxicity, pregnancy, and hypoxia (24, 27, 28). Recent data also suggest that β cell 
dedifferentiation occurs in T1D. For example, in humans, the frequency of  degranulated chromogranin 
A+/hormone– cells increases in pancreata from T1D patients (29). Moreover, in NOD mice, a subpopu-
lation of  degranulated β cells resists immunological attacks while decreasing β cell markers and gaining 
pancreatic progenitor traits (26). We undertook the present study to elucidate the mechanisms involved in 
human β cell dedifferentiation in T1D.
Enteroviral infections have been associated with the development of  T1D, but our knowledge of  the 
way enteroviruses act on human β cells and induce diabetes is limited. A number of  rodent models have 
been useful to better understand mechanisms of  enterovirus-induced β cell dysfunction. However, several 
differences exist between human and rodent β cells in response to viral assault. As access to primary human 
islet preparations is limited, we recently developed a functional human β cell line by lentiviral transduction 
of  2 RIP-regulated oncogenes (SV40T and hTERT) (15), and validated in the present study this line to 
Figure 3. The NF-κB pathway is involved in SOX9 induction by PolyI:C. (A) Gene set enrichment analysis of global transcriptomic data representing 
pathways regulated following PolyI:C treatment with the corresponding FDR q values. The x axis represents the percentage of regulated genes in the 
corresponding pathway. (B) Immunostaining for RELA indicates that PolyI:C treatment (24 hours) induces the nuclear translocation of RELA. Scale 
bars: 25 μm. Arrowheads point to nuclear RELA localization. The insets show higher-magnification images (×3 magnification; scale bars: 5 μm). n = 
3, representative images of 3 independents experiments. (C) EndoC-βH1 cells were either mock transfected (CTRL) or transfected with PolyI:C and the 
NF-κB targets TNFA, IL8, and IL6 were analyzed 24 hours later by qPCR (n = 3). (D–F) EndoC-βH1 cells were transfected with control nontarget siRNA 
(siCTRL) or siRNA targeting RELA (siRELA). They were next either mock transfected or transfected with PolyI:C 24 hours later, RNA was prepared for 
RT-qPCR (n = 3) (D), and proteins for Western blot analyses (n = 3, representative blot of 3 independent experiments) (E and F). Data from immuno-
fluorescence, RT-qPCR, and Western blots represent the mean ± SD of 3 independent experiments. *P < 0.05; **P < 0.01; and ***P < 0.001 relative to 
control by Student’s t test or ANOVA with Bonferroni’s correction for multiple comparisons.
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Figure 4. Potent NF-κB activa-
tors induce SOX9 expres-
sion in human β cells. (A 
and B) EndoC-βH1 cells were 
treated with proinflammatory 
cytokines (TNF-α, IL-1β, and 
IFN-γ). (A) SOX9, HES1, MYC, 
MAFA, and SLC30A8 mRNAs 
were analyzed 72 hours later 
(n = 3). (B) SOX9 protein was 
analyzed 72 hours later (n = 3, 
representative Western blot of 
3 independent experiments). 
(C) Human islets were exposed 
to IL-1β, TNF-α, and IFN-γ for 
72 hours. Islets were harvested 
prior to immunofluorescence 
staining. Insulin is in red and 
SOX9 is in green. Scale bars: 
25 μm. Arrowheads point to 
insulin+ (INS+) cells that stain 
positive for SOX9 following 
cytokine treatment. The insets 
show higher-magnification 
images (×2.4 magnification; 
scale bar: 5 μm). n = 2, repre-
sentative images of 2 inde-
pendent experiments. (D–F) 
EndoC-βH1 cells were trans-
fected with control nontarget 
siRNA (siCTRL) or siRNA 
targeting RELA (siRELA). They 
were next treated with PMA 
for 8 hours. RNA was prepared 
for RT-qPCR (n = 3) (D) and 
proteins for Western blot 
analyses (E and F) (n = 3). Data 
from RT-qPCR and Western 
blot represented as the mean 
± SD of 3 independent experi-
ments. *P < 0.05, **P < 0.01, 
and ***P < 0.001 relative to 
control by Student’s t test.
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model β cell infection by viruses. We demonstrated that infection of  EndoC-βH1 cells with enteroviruses 
induced the expression of  the major viral capsid protein VP1. Moreover, treatment of  EndoC-βH1 cells 
with PolyI:C induced a gene expression profile that resembles the one previously observed following infec-
tion of  human pancreatic islets by coxsackieviruses (10, 21).
We observed marks of  dedifferentiation following PolyI:C treatment characterized by a decreased 
expression of  β cell–specific genes such as INS, MAFA, and SLC30A8. Such decrease in gene expression 
was independent of  β cell death, which corroborates recent data that indicate that enteroviral infection of  
human islets results in a loss of  insulin production (10). Interestingly, we observed that glucose-stimulated 
insulin secretion was diminished following PolyI:C treatment. In parallel with the decrease in β cell–spe-
cific genes and function, we observed a marked increase of  progenitor markers such as SOX9, HES1, and 
MYC as additional marks of  dedifferentiation. It is noteworthy that the expression of  the pancreatic endo-
crine progenitor marker NEUROG3 as well as ALDH1A3 that are both increased in β cell dedifferentiation 
in type 2 diabetes (T2D) (28, 30, 31) were not induced in our model, suggesting alternative mechanisms of  
β cell dedifferentiation following viral infection.
We focused on the induction of  SOX9, a transcription factor expressed in multipotent pancreatic pro-
genitors and duct cells that contribute to the development of  endocrine and exocrine cells of  the adult pan-
creas (32). Healthy β cells do not express SOX9 (32), while aberrant SOX9 expression has been observed 
in islets of  db/db mice, a model of  T2D (33) and in mouse β cells following activation of  the Hedgehog 
signaling pathway (34) or under hypoxic conditions (24). Remarkably, ectopic expression of  SOX9 itself  led 
to β cell dedifferentiation as revealed by a decrease in β cell–specific genes both in mice (24) and in humans 
(the present study).
There are around 106 islets dispersed in the human pancreas. The way by which viruses could induce an 
efficient decrease in functional β cell mass and β cell dedifferentiation in this islet setting remains obscure. 
One hypothesis is that following infection, viruses would replicate in a recurrent fashion in the human 
islets, and over weeks or months the viruses would infect β cells. This hypothesis is supported by the fact 
that signs of  viral infection such as expression of  the viral capsid protein VP1 are detected in the islets of  
the majority of  brain-dead organ donors with T1D, i.e., potentially years after infection (35). Our data sup-
port an additional hypothesis, in which viral infection would activate the NF-κB and interferon regulatory 
factor (IRF) pathways in a limited number of  β cells within an islet that would induce the production and 
secretion of  NF-κB and IRF downstream cytokines. Such proinflammatory cytokines would next act in 
a paracrine fashion on neighboring β cells to induce their dedifferentiation, creating a vicious cycle (36, 
37). Such a hypothesis is supported by our data that demonstrate that (a) PolyI:C treatment induces the 
production of  cytokines such as IFN-α and TNF-α by EndoC-βH1 cells; and (b) the conditioned medium 
of  PolyI:C-treated EndoC-βH1 cells induces SOX9 expression when added to naive β cells, as is the case 
when the cells are treated with IFN-α and TNF-α. We thus propose that within islets, viral infection could 
induce dedifferentiation in a paracrine non–cell-autonomous fashion, which would represent a mechanism 
to increase the process of  human β cell dedifferentiation following viral infection.
Our data indicate that PolyI:C alters β cell identity and gives rise to a partial progenitor-like gene 
expression profile. In particular, PolyI:C induces the expression of  the progenitor marker SOX9 in an 
NF-κB–dependent manner. We searched for SOX9 targets in human β cells. It was previously demon-
strated that HNF1B, ONECUT1, and FOXA2 were SOX9 targets in a mouse pancreatic duct cell line (23). 
None of  these genes were induced (neither by PolyI:C treatment nor SOX9 overexpression), which may 
be due to species (mouse vs. human) or cell type (duct vs. β cells) differences. By mining transcriptomic 
data obtained from SOX9 overexpression or PolyI:C treatment in EndoC-βH1 cells, we discovered poten-
tially new SOX9 targets such as CTGF, DEPTOR, MAML2, and LRRTM2. Interestingly, by analyzing 
transcriptomic data from NOD mouse β cells that survive immunological attack (26), we discovered 
Figure 5. SOX9 is also induced in a paracrine non–cell-autonomous fashion. (A and B) EndoC-βH1 cells were incubated with conditioned medium from 
mock- (CTRL) or PolyI:C-transfected cells. SOX9, MYC, and MAFA mRNA (n = 3) (A) and SOX9 protein (n = 3; representative Western blot of 3 independent 
experiments) (B) were analyzed 72 hours later. (C and D) EndoC-βH1 cells were either mock transfected (CTRL) or transfected with PolyI:C and analyzed 24 
hours later. (C) Heatmap from global transcriptomic analysis represents upregulated IFN, IL, and TNF family members (n = 3). (D) RT-qPCR analysis of IFNA2 
and IFNB1 expression (n = 3). (E and F) EndoC-βH1 cells were treated with TNF-α and IFN-α. SOX9 mRNA (n = 3) (E) and protein (n = 3; representative West-
ern blot of 3 independent experiments) (F) were analyzed 72 hours later. Data from RT-qPCR and Western blots represent the mean ± SD of 3 independent 
experiments. *P < 0.05; **P < 0.01; and ***P < 0.001 relative to control by Student’s t test or ANOVA with Bonferroni’s correction for multiple comparisons.
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that the expression of  Sox9 and its 4 above-described targets was induced, further supporting SOX9 
and its targets as markers of  β cell dedifferentiation. In chondrocytes, CTGF was recently demonstrated 
as a direct target of  SOX9, with a role in differentiation (38). In the pancreas, CTGF is involved in β 
cell proliferation and regeneration (39–41). Following immunological attack, as observed during T1D 
progression, dedifferentiated cells could represent a pool of  progenitor-like cells that can eventually pro-
liferate and regenerate through SOX9 and CTGF. These dedifferentiation/redifferentiation cycles may 
lead to continuous turnover of  β cells that are again targeted by the immune system or they could lead 
to a residual subpopulation of  β cells, as observed in T1D patients with a disease duration of  50 years or 
longer (termed “medalists”) (42). Understanding whether dedifferentiated cells can redifferentiate into β 
cells and developing strategies to protect them from immune attacks may identify new therapeutic targets 
to replenish a sufficient amount of  insulin-positive cells in vivo.
Methods
Culture of  EndoC-βH1 cells and treatment. The human pancreatic β cell line EndoC-βH1 was cultured in 5.6 
mM glucose Dulbecco’s Modified Eagle’s Medium (DMEM, Thermo Fisher Scientific) supplemented with 
2% BSA fraction V (Roche), 50 μM β-mercaptoethanol (Sigma-Aldrich), 5.5 μg/ml transferrin (Sigma-
Aldrich), 6.7 ng/ml Na2SeO3, 10 mM nicotinamide (Calbiochem), and 100 μg/ml streptomycin and 100 
U/ml penicillin (Thermo Fisher Scientific). Cells were seeded at 9 × 104 cells/cm2 on plates coated with 
1.2% Matrigel containing 3 μg/ml fibronectin (both Sigma-Aldrich) and cultured at 37°C and 5% CO2 as 
previously described (15).
EndoC-βH1 cells were transfected with 1 μg/ml of  PolyI:C (InvivoGen) using Lipofectamine 
RNAiMAX reagent (Thermo Fisher Scientific) as previously described (43). The following compounds 
were used for treatment: 100 ng/ml PMA (Santa Cruz Biotechnology); 2,000 U/ml IFN-γ (R&D Systems); 
1,100 U/ml TNF-α (R&D Systems); 1,000 U/ml IL-1β (R&D Systems); 2,000 U/ml IFN-α (Roche); and 
10 μM PDTC (Santa Cruz Biotechnology).
Glucose-stimulated insulin secretion. Five days after PolyI:C transfection, EndoC- βH1 cells were starved 
in DMEM containing 0.5 mM glucose. After a 24-hour starvation, cells were washed twice and then pre-
incubated in Krebs-Ringer bicarbonate HEPES buffer (KRBH) containing 0.2% fatty acid–free BSA and 0 
mM glucose for 1 hour. Insulin secretion was measured following a 40-minute incubation with KRBH con-
taining 0.2% fatty acid–free BSA and 0 mM or 20 mM glucose. Insulin secretion and intracellular insulin 
were measured by ELISA as previously described (15).
Human islets and treatment. Human islets were obtained from 7 donors. On the day of  receiving the 
samples, approximately 100 human islets were handpicked for each condition, washed in PBS, and treated 
with 1 ml Accutase (PAA Laboratories) for 5 minutes at 37°C. Partial dissociation of  the human islets was 
achieved with slow pipetting and Accutase was removed after a centrifugation step. The cells were seeded 
on  Matrigel/fibronectin–coated coverslips and cultured for 24 hours in the same medium as used for 
EndoC-βH1 cells and transfected with PolyI:C as described above.
Assessment of  cell death. Apoptotic and necrotic cell death was determined following annexin-V/prop-
idium iodide staining (Biolegend). AnnexinV and propidium iodide double-negative cells were considered 
alive and sorted using a FACSAria III cell sorter (BD Bioscience).
RNA isolation, reverse transcription, and qPCR. An RNeasy Micro kit (Qiagen) was used to extract 
total RNA from EndoC-βH1 cells. A First-Strand cDNA kit (Thermo Fisher Scientific) was used to 
synthesize cDNA. RT-qPCR was performed using Power SYBR Green mix (Applied Biosystems) with 
a QuantStudio 3 analyzer. Custom primers were designed with IDT Primer-Quest online software and 
the efficiency was determined for each with a serial dilution of  cDNA samples from EndoC-βH1 cells. 
PPIA or ACTB transcript levels were used for normalization of  each sample. Probe sequences are listed 
in Supplemental Table 1.
Figure 6. Genes induced in EndoC-βH1 cells by SOX9. (A) EndoC-βH1 cells were either mock transfected (CTRL) or transfected with PolyI:C and 
analyzed 24 hours later. Heatmap from global transcriptomic analysis represents previously described SOX9 target genes (n = 3). (B–E) EndoC-βH1 
cells were transfected with MCS-ires-GFP, SOX9WT-ires-GFP, VP16-ires-GFP, or VP16-SOX9ΔTAD-ires-GFP plasmid. GFP+ cells were sorted by FACS 48 
hours later and RNAs were prepared (n = 2–6). (B and C) RT-qPCR analyses (n = 6). (D and E) Global transcriptomic analyses with Venn diagram and 
heatmap that represent genes upregulated (>1.5-fold) by SOX9WT-ires-GFP and VP16-SOX9ΔTAD-ires-GFP (n = 2). Data from RT-qPCR represent the 
mean ± SD. *P < 0.05, **P < 0.01 and ***P < 0.001 relative to control by Student’s t test. ns, not significant.
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Gene expression analysis. EndoC-βH1 cells were isolated, RNA extracted, and gene expression assessed 
using the Affymetrix 2.0ST gene chip. Microarray data and all experimental details are available in the 
NCBI’s Gene Expression Omnibus (GEO) database (accession GSE104196). GSEA software and the Bio-
logical Process database of  the Gene Ontology Consortium were used for gene expression comparisons (44).
siRNA transfection. EndoC-βH1 cells were passaged and transfected using Lipofectamine RNAiMAX 
(Life Technologies) 24 hours later. SMARTpool siRNA for human RELA or SOX9, or ON-TARGETplus 
nontargeting control pool (siCTRL) were used (Dharmacon, GE healthcare Life Sciences) at a final con-
centration of  80 nM. Briefly, siRNA and Lipofectamine RNAiMAX were combined in OptiMEM and 
applied to the cells. Medium was replaced 2.5 hours later with fresh EndoC-βH1 culture medium.
Enterovirus infection. For infection, 7.5 × 105 EndoC-βH1 cells were incubated with 5 × 104 of  50% tis-
sue culture infectious dose (TCID50) CVB5 Faulkner, EV-9 Barty, or DM for 2 hours in infection medium 
(1× Hanks’ medium without FBS, 0.44% NaHCO3) as described previously (12). Twenty-four hours after 
infection, cells were harvested for RNA preparation or protein analysis. Five hundred human islets were 
infected with 5 × 107 TCID50/ml for 2 hours in islet culture medium (RPMI plus 5.5 mM glucose and 10% 
FBS). Twenty-four hours after infection, islets were harvested for protein analysis.
Preparation of  conditioned medium. EndoC-βH1 cells were transfected with or without PolyI:C and media 
were changed 2.5 hours later. Conditioned media were recovered after 24 hours, filtered, incubated with or 
without RNAse-A (1 mg/ml, Qiagen) for 30 minutes at 37°C, and added to untreated (naive) EndoC-βH1 cells.
Immunostaining and immunoblotting. EndoC-βH1 cells were cultured on Matrigel/fibronectin–coated 
coverslips and processed for RELA immunostaining as previously described (45). Human islets cultured on 
Matrigel/fibronectin–coated coverslips and treated with PolyI:C were processed for SOX9 (1/500; ab5535; 
Millipore) and insulin (1:1,000; Sigma-Aldrich). Handpicked human islets were treated with cytokines for 
72 hours. Tissues were fixed in 10% formalin and processed for immunohistochemistry for SOX9 and 
insulin using a NxGen decloaking chamber (Biocare). The secondary antibodies were Alexa Fluor 488 goat 
anti-rabbit (1:400; Invitrogen) and Alexa Fluor 594 goat anti-mouse (1:400; Jackson ImmunoResearch).
For immunoblot assays, cells were lysed in RIPA buffer and sonicated. Equal amounts of protein (20 
μg) were separated in a 4%–12% Bis-Tris gel and transferred onto a PVDF membrane using an iBLOT2 Dry 
Blotting System (Thermo Fisher Scientific). Membranes were immunoblotted with the following antibodies: 
MAFA (1/500; Gift from Alireza Rezania, Betalogics), SOX9 (1/500; ab5535; Millipore), VP1 (1/500; Gift 
from Merja Roivainen, Helsinki, Finland), RELA (1/250; sc8008; Santa Cruz Biotechnology), and tubulin 
(1/2,000; T9026; Sigma-Aldrich). Species-specific HRP-linked secondary antibodies (Cell Signaling Technol-
ogy) were used for detection and visualization was performed on an ImageQuant LAS 4000 following ECL 
exposure (GE Healthcare).
Plasmid construction. All retroviral vector plasmids used for transfection were derived from the 
pPRIG vector or its relatives (46, 47). For safety measures, retroviral psi (Ψ) packaging element was 
removed in each plasmid by an EheI digestion followed by religation (48). The pcDNA3-Flag-SOX-
9WT and the RCAS-Flag-SOX9ΔTAD plasmids were gifts from Philippe Jay and Pascal De Santa 
Barbara (both from INSERM-CNRS, Montpellier, France). The pPRIGΔΨ-FlagSOX9WT (referred to 
here as SOX9WT) was constructed following pcDNA3-FlagSOX9WT digestion with BamHI-EcoRI. 
The digested DNA was then subcloned into the pPRIGΔΨ bicistronic vector digested by the same 
enzymes. The pPRIGΔΨ-VP16-SOX9ΔTAD (referred to as VP16-SOX9ΔTAD) was constructed in 
4 steps. First, the RCAS-Flag-SOX9ΔTAD was digested with ClaI and SalI and subcloned into the 
pPRIZΔΨ vector digested by the same enzymes. The pcDNA3-FlagSOX9WT plasmid was digested 
by NdeI-PasI and then subcloned into the pPRIZΔΨ-FlagSOX9ΔTAD vector digested by the same 
enzymes (referred as pPRIZΔψ-NWT-FlagSOX9ΔTAD). The multiple cloning site (MCS) of  the 
pPRIGΔΨ-VP16-MCS plasmid was shortened by a AvaIII-SdaI digestion (as pPRIGΔψ-VP16-sMCS). 
Figure 7. Potentially new SOX9 targets in dedifferentiated human β cells. (A) Venn diagram with genes upregulated (>2-fold) in EndoC-βH1 cells 
treated with PolyI:C and following ectopic expression of SOX9/VP16-SOX9ΔTAD. Genes upregulated by both PolyI:C and SOX9/VP16-SOX9ΔTAD are 
shown in red. (B) EndoC-βH1 cells were transfected with MCS-ires-GFP, SOX9WT-ires-GFP, VP16-ires-GFP, or VP16-SOX9ΔTAD-ires-GFP plasmid. GFP+ 
cells were sorted by FACS 48 hours later and RNA was prepared for RT-qPCR analyses (n = 3). (C–E) EndoC-βH1 cells were transfected with control 
nontarget siRNA (siCTRL) or siRNA targeting SOX9 (siSOX9). They were next either mock transfected or transfected with PolyI:C. Twenty-four hours 
later, proteins were prepared for Western blot analyses (n = 3) (C and D) and RNA for RT-qPCR (n = 3) (E). Data from RT-qPCR and Western blot 
represent the mean ± SD of 3 independent experiments. *P < 0.05; **P < 0.01; and ***P < 0.001 relative to control by Student’s t test or ANOVA with 
Bonferroni’s correction for multiple comparisons. ns, not significant. 
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Lastly, pPRIZΔψ-NWT-FlagSOX9ΔTAD was digested with SdaI–PstI and then subcloned into 
pPRIGΔψ-VP16-sMCS digested with PstI–MunI. Sequencing validated all developed plasmids. The 
plasmids used here are referred to as MCS-ires-GFP (CTRL), SOX9WT-ires GFP, VP16-ires-GFP, and 
VP16-SOX9ΔTAD-ires-GFP.
Plasmid transfection. EndoC-βH1 cells were passaged and transfected using Lipofectamine 2000 (Life 
Technologies) 24 hours later. MCS-ires-GFP (CTRL), SOX9WT-ires GFP, VP16-ires-GFP, or VP16-
SOX9ΔTAD-ires-GFP was used at a final of  1 μg/ml. Briefly, plasmid and Lipofectamine 2000 were com-
bined in OptiMEM and applied to the cells. Three hours later, the medium was replaced with fresh EndoC-
βH1 culture medium.
Luciferase assay. SOX9 response element COL2A1 promoter and SOX9 binding motif  were gifts from 
Laura Bridgewater (Brigham Young University, Provo, Utah, USA) and Marc van de Wetering (Hubrecht 
Institute, Utrecht, The Netherlands), respectively. Cells were cotransfected with a SOX9 response element–
driven firefly luciferase reporter gene, with either MCS-ires-GFP (CTRL), SOX9WT-ires GFP, VP16-ires-
GFP, or VP16-SOX9ΔTAD-ires-GFP and Renilla luciferase at a final concentration of  1 μg/ml. Firefly and 
Renilla luciferase activity was measured with a Dual Luciferase reporter assay system (Promega) following 
the manufacturer’s instructions. Firefly luciferase activity was normalized to Renilla luciferase activity to 
correct for variation in transfection efficiency.
Statistics. Graphs were constructed by using Prism 6 software (GraphPad). Quantitative data are pre-
sented as the mean ± SD from 3 independent experiments. Statistical significance was estimated using a 
1-tailed Student’s t test. A P value less than 0.05 was considered significant.
Study approval. Human pancreata were obtained from brain-dead donors after informed consent was 
signed from next-of-kin, and processed for islet isolation according to the procedures approved by the ethics 
committee of  the University of  Pisa, Italy, the French Agency of  Biomedicine, and King’s College Hospital 
NHS Foundation Trust (London, United Kingdom).
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